The catheter related bloodstream infection market was valued at US$ 1.53 billion in 2023 and is predicted to reach US$ 2.52 billion by the end of 2033, representing an impressive CAGR of 5.13% from 2024 to 2033. The increasing geriatric population and chronic conditions are driving the growth of the market.
Download a sample of this report @ https://www.towardshealthcare.com/download-statistics/5157
Key Takeaways/ Important Points to Note
- By region, North America dominated the catheter related bloodstream infection market in 2023.
- By region, Asia Pacific is expected to be the fastest-growing region during the forecast period.
- By treatment type, the anti-microbial agents segment dominated the market in 2023.
- By source of infection, the Coagulase-negative Staphylococcus segment dominated the market in 2023.
- By distribution channel, the hospital pharmacies segment dominated the market.
- By distribution channel, the online pharmacies segment is anticipated to show significant growth during the forecast period.
Industry at a Glance
The catheter related bloodstream infection market functions to provide treatment, medication, and other resources for monitoring and treating bloodstream infections that occur due to catheters. Catheters are tubes made out of silicone, Teflon, or latex that are inserted in the body for draining or feeding fluid. Some of the major applications of catheters include feeding, fluid drainage from wounds, and draining of the bladder. Catheter-related bloodstream infection is the presence of bacteremia that originated from an intravenous catheter. Such infections are very frequent, lethal, and costly. As the number of chronic diseases and the old-age population increase, the number of surgeries also increases. The need for catheters is also increasing due to surgeries. Along with the technological advancements and continuous research, it promotes the growth of the catheter related bloodstream infection market.
Top Companies of the Catheter Related Bloodstream Infection Market
- Teva Pharmaceutical Industries Ltd.
- SteriMax Inc.
- Sanofi AG
- Pfizer Inc.
- Novartis
- Merck & Co., Inc.
- GSK plc
- Fresenius SE & Co. KGaA
- Eli Lilly and Company
- B. Braun Medical Inc.
- Aurobindo Pharma Limited
- Citius Pharma
- Cormedix
Segments Covered in Catheter Related Bloodstream Infection Market Report
By Treatment Type
- Anti-microbial Agents
- Antibiotic Lock Therapy
By Source of Infection
- Coagulase-negative Staphylococcus
- S. aureus
- Enteric Gram-negative Bacilli
- Yeasts
- Enterococci & Streptococci
- Pseudomonas
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Segments Covered in Catheter Related Bloodstream Infection Market Report
By Treatment Type
- Anti-microbial Agents
- Antibiotic Lock Therapy
By Source of Infection
- Coagulase-negative Staphylococcus
- S. aureus
- Enteric Gram-negative Bacilli
- Yeasts
- Enterococci & Streptococci
- Pseudomonas
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Segments Covered in Catheter Related Bloodstream Infection Market Report
By Treatment Type
- Anti-microbial Agents
- Antibiotic Lock Therapy
By Source of Infection
- Coagulase-negative Staphylococcus
- S. aureus
- Enteric Gram-negative Bacilli
- Yeasts
- Enterococci & Streptococci
- Pseudomonas
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/catheter-related-bloodstream-infection-market-sizing
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5157
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
